Researchers

  • Asunción Ávila

    Vascular risk

    Phd
  • Luis Miguel Ceresuela

    Vascular risk

  • Manuel Jesús Gómez-choco

    Vascular risk

    Phd
  • Montserrat Martín-baranera

    Vascular risk

    Phd
  • Pedro Armario

    Vascular risk

    Phd
  • Peter Blanch

    Vascular risk

    Phd
  • Rachel Hernandez

    Vascular risk

    Phd

Contact the group

Form

Projects

    • Year 2015
    • L'Hospitalet General Hospital

    COPPADIS-15 Cohort of Patients with Parkinson's Disease in Sapain,

    • DISTRICT ATTORNEY:

      from the Spanish Foundation for Parkinson's Research

    • TYPE E:

      EPA

    • Year 2015
    • Hospitalet General Hospital

    COPPADIS-15 Cohort of Patients with Parkinson's Disease in Sapain,

    • DISTRICT ATTORNEY:

      from the Spanish Foundation for Parkinson's Research

    • TYPE E:

      EPA

    • Year 2015
    • Sant Joan Despí Moisès Broggi Hospital

    Multicentric, observational study to determine the profile and management of antithrombotic treatment in patients with non-valvular atrial fibrillation who attend the internal medicine services of Spanish hospitals (PROFILE STUDY),

    • DISTRICT ATTORNEY:

      Bristol-Myers Squibb SAU

    • TYPE E:

      EPA

  • Vascular risk

    Researcher
    • Year 2014
    • Hospital General de l'Hospitalet

    Multicenter study to evaluate the prevalence of Niemann-Pick C disease in patients with movement disorders.

    • DISTRICT ATTORNEY:

      Movement Disorders Group (GTEM) of the Spanish Society of Neurology (SEN)

    • TYPE E:

      PI

  • Vascular risk

    Researcher
    • Year 2014
    • Hospital General de l'Hospitalet

    Multicenter study to evaluate the prevalence of Niemann-Pick C disease in patients with movement disorders.

    • DISTRICT ATTORNEY:

      Movement Disorders Group (GTEM) of the Spanish Society of Neurology (SEN)

    • TYPE E:

      PI

  • Vascular risk

    Researcher
    • Year 2014
    • Sant Joan Despí Moisès Broggi Hospital

    Validation of the ACTS questionnaire in patients with atrial fibrillation (AF) treated with oral anticoagulants (ACOs) in internal medicine and neurology clinics in Spain. Studio ALADIN,

    • DISTRICT ATTORNEY:

      BAYER HISPANIA SL

    • TYPE E:

      EPA

  • Vascular risk

    Researcher
    • Year 2014
    • Sant Joan Despí Moisès Broggi Hospital

    Evaluation of the 24-hour central arterial pressure, its circadian rhythms and its relationship with organic damage,

    • DISTRICT ATTORNEY:

      Dr. Alejandro de la Sierra - Hospital Mútua de Terrassa

    • TYPE E:

      PI

    • Year 2014
    • Sant Joan Despí Moisès Broggi Hospital

    Validation of the ACTS questionnaire in patients with atrial fibrillation (AF) treated with oral anticoagulants (ACOs) in internal medicine and neurology clinics in Spain. Studio ALADIN,

    • DISTRICT ATTORNEY:

      BAYER HISPANIA SL

    • TYPE E:

      EPA

    • Year 2014
    • L'Hospitalet General Hospital

    Multicenter study to evaluate the prevalence of Niemann-Pick C disease in patients with movement disorders.

    • DISTRICT ATTORNEY:

      Movement Disorders Group (GTEM) of the Spanish Society of Neurology (SEN)

    • TYPE E:

      PINE TREE

    • Year 2014
    • Sant Joan Despí Moisès Broggi Hospital

    Validation of the ACTS questionnaire in patients with atrial fibrillation (AF) treated with oral anticoagulants (ACOs) in internal medicine and neurology clinics in Spain. Studio ALADIN,

    • DISTRICT ATTORNEY:

      BAYER HISPANIA SL

    • TYPE E:

      EPA

Lines of action

  • Resistant hypertension and refractory hypertension
  • Arterial stiffness in hypertension and cerebrovascular disease
  • Small vessel cerebrovascular disease: Lacunar infarction
  • Factors associated with stroke recurrences
  • Thrombolytic treatment and acute stroke care circuits
  • Prognostic value of premorbid BP and BP in the acute phase of stroke

Documents

Information of interest

Links